Skip to main content
. 2015 Jun;41(2):61–66. doi: 10.5152/tud.2015.65624

Table 1.

Clinical and pathological properties of RP patients

Patients (n) 152
Age 63.7±7.2 years
PSA 5.25±4.22 ng/mL
Tumor volume 14.4±12.9 mL
PNI 32.9% (50/152)
SVI 11.8% (18/152)
ECE 19.7% (30/152)
CI 13.2% (20/152)
PSM 11.8% (18/152)
BCR 25% (38/152)

PSA: prostate-specific antigen; PNI: perineural invasion; SVI: seminal vesicle invasion; ECE: extracapsular extension; CI: capsule invasion; PSM: positive surgical margins; BCR: biochemical recurrence